• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[S-100蛋白阳性朗格汉斯细胞和Leu-M1阳性肿瘤细胞对甲状腺乳头状癌预后的重要性]

[The importance of S-100 protein positive Langerhans cells and Leu-M1 positive tumor cells for prognosis of papillary thyroid cancer].

作者信息

Willgeroth C, Floegel R, Rösler B

机构信息

Institut für Pathologie, Medizinischen Akademie Magdeburg.

出版信息

Zentralbl Chir. 1992;117(11):603-6.

PMID:1361703
Abstract

In a period of 10 years (1981-90) papillary thyroid carcinomas were found in 124 cases. In 95 cases we were able to perform immunohistochemical studies for Leu-M1 antigen and S-100 protein. The examination of these cases has revealed that the presence of S-100 positive Langerhans cells yields no additional information for the prognosis of the papillary thyroid carcinoma. But we observed that the existence of Leu-M1 positive tumour cells is connected with a poor postoperative course of disease in comparison to Leu-M1 negative tumours.

摘要

在10年期间(1981 - 1990年),共发现124例甲状腺乳头状癌。其中95例能够进行针对Leu - M1抗原和S - 100蛋白的免疫组织化学研究。对这些病例的检查显示,S - 100阳性朗格汉斯细胞的存在对于甲状腺乳头状癌的预后并无额外信息。但我们观察到,与Leu - M1阴性肿瘤相比,Leu - M1阳性肿瘤细胞的存在与术后疾病进程不佳有关。

相似文献

1
[The importance of S-100 protein positive Langerhans cells and Leu-M1 positive tumor cells for prognosis of papillary thyroid cancer].[S-100蛋白阳性朗格汉斯细胞和Leu-M1阳性肿瘤细胞对甲状腺乳头状癌预后的重要性]
Zentralbl Chir. 1992;117(11):603-6.
2
[Immunohistology and prognosis in thyroid cancer. Determination of the malignancy potential of papillary and medullary neoplasms by the detection of S-100 protein and Leu-M1 antigen].甲状腺癌的免疫组织学与预后。通过检测S-100蛋白和Leu-M1抗原确定乳头状和髓样肿瘤的恶性潜能
Acta Med Austriaca. 1989;16(1):2-5.
3
Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland.Leu-M1免疫染色在甲状腺乳头状癌中的预后意义
Virchows Arch A Pathol Anat Histopathol. 1987;411(5):435-9. doi: 10.1007/BF00735224.
4
Diffuse sclerosing variant of papillary thyroid carcinoma. S-100 protein immunocytochemistry and prognosis.甲状腺乳头状癌的弥漫性硬化变异型。S-100蛋白免疫细胞化学与预后。
Virchows Arch A Pathol Anat Histopathol. 1990;416(4):367-71. doi: 10.1007/BF01605298.
5
Leu-M 1 immunoreactivity in papillary carcinomas of the thyroid gland; microcarcinoma, encapsulated, conventional and diffuse sclerosing subtypes.甲状腺乳头状癌中的Leu-M 1免疫反应性;微癌、包膜型、经典型和弥漫硬化型亚型。
Virchows Arch A Pathol Anat Histopathol. 1991;419(5):447-8. doi: 10.1007/BF01605080.
6
[Immunohistochemical studies of mononuclear cellular infiltrates of papillary, follicular and anaplastic thyroid cancers].[乳头状、滤泡状和未分化甲状腺癌单核细胞浸润的免疫组织化学研究]
Laryngorhinootologie. 1994 Apr;73(4):183-8. doi: 10.1055/s-2007-997107.
7
[Prognostic value of e-cadherin in papillary thyroid carcinoma].
Chirurg. 1998 Feb;69(2):186-90. doi: 10.1007/s001040050394.
8
Association of CD1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: a cytologic and immunocytochemical evaluation.CD1a 阳性树突状细胞与甲状腺细针抽吸标本中甲状腺乳头状癌的关系:细胞形态学和免疫细胞化学评估。
Cancer Cytopathol. 2013 Apr;121(4):206-13. doi: 10.1002/cncy.21239. Epub 2012 Oct 5.
9
Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data.甲状腺乳头状癌患者的树突状/朗格汉斯细胞与预后。106例甲状腺肿瘤的免疫细胞化学研究及其与随访数据的相关性。
Am J Clin Pathol. 1988 Mar;89(3):295-300. doi: 10.1093/ajcp/89.3.295.
10
[Blood group antigen expression in papillary carcinoma of the thyroid gland. An immunohistochemical and clinical study of expression of Lewis, ABO and related antigens].[甲状腺乳头状癌中的血型抗原表达。Lewis、ABO及相关抗原表达的免疫组织化学与临床研究]
Langenbecks Arch Chir. 1996;381(2):102-13. doi: 10.1007/BF00183940.

引用本文的文献

1
Stage-Specific Embryonic Antigen-1 (SSEA-1) Expression in Thyroid Tissues.甲状腺组织中阶段特异性胚胎抗原-1(SSEA-1)的表达
Endocr Pathol. 2016 Dec;27(4):271-275. doi: 10.1007/s12022-016-9448-1.
2
CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer.
Br J Cancer. 2003 Aug 4;89(3):533-8. doi: 10.1038/sj.bjc.6601114.